Our mission is to make a difference in time by striving to improve outcomes for potential lung cancer patients through early predictive technologies; provide cost savings to patients, payers, and providers; and to provide a fair return on investment to shareholders and other stakeholders.
ProLung is committed to making a positive and significant impact on the healthcare community and to being socially responsible in all its endeavors.
News & Events
Executive Team and Board of Directors
Investor Relations Contact
Jennifer K. Zimmons, Ph.D.